These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1807 related items for PubMed ID: 19768400

  • 21. Vaccines for seasonal and pandemic influenza.
    Nichol KL, Treanor JJ.
    J Infect Dis; 2006 Nov 01; 194 Suppl 2():S111-8. PubMed ID: 17163383
    [Abstract] [Full Text] [Related]

  • 22. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
    Wharton M, Strikas RA, Harpaz R, Rotz LD, Schwartz B, Casey CG, Pearson ML, Anderson LJ, Advisory Committee on Immunization Practices, Healthcare Infection Control Practices Advisory Committee.
    MMWR Recomm Rep; 2003 Apr 04; 52(RR-7):1-16. PubMed ID: 12710832
    [Abstract] [Full Text] [Related]

  • 23. Live attenuated versus inactivated influenza vaccine in infants and young children.
    Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM, CAIV-T Comparative Efficacy Study Group.
    N Engl J Med; 2007 Feb 15; 356(7):685-96. PubMed ID: 17301299
    [Abstract] [Full Text] [Related]

  • 24. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.
    Belshe RB, Ambrose CS, Yi T.
    Vaccine; 2008 Sep 12; 26 Suppl 4():D10-6. PubMed ID: 18611422
    [Abstract] [Full Text] [Related]

  • 25. Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults.
    Hoft DF, Lottenbach KR, Blazevic A, Turan A, Blevins TP, Pacatte TP, Yu Y, Mitchell MC, Hoft SG, Belshe RB.
    Clin Vaccine Immunol; 2017 Jan 12; 24(1):. PubMed ID: 27847366
    [Abstract] [Full Text] [Related]

  • 26. [Technical guidelines for seasonal influenza vaccination in China (2019-2020)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jan 06; 54(1):21-36. PubMed ID: 31914565
    [Abstract] [Full Text] [Related]

  • 27. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B, CAIV-T Asthma Study Group.
    Pediatr Infect Dis J; 2006 Oct 06; 25(10):860-9. PubMed ID: 17006278
    [Abstract] [Full Text] [Related]

  • 28. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD, CAIV-T Study Group.
    Pediatr Infect Dis J; 2006 Oct 06; 25(10):870-9. PubMed ID: 17006279
    [Abstract] [Full Text] [Related]

  • 29. Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial.
    Cadorna-Carlos JB, Nolan T, Borja-Tabora CF, Santos J, Montalban MC, de Looze FJ, Eizenberg P, Hall S, Dupuy M, Hutagalung Y, Pépin S, Saville M.
    Vaccine; 2015 May 15; 33(21):2485-92. PubMed ID: 25843270
    [Abstract] [Full Text] [Related]

  • 30. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season.
    Kawai AT, Li L, Kulldorff M, Vellozzi C, Weintraub E, Baxter R, Belongia EA, Daley MF, Jacobsen SJ, Naleway A, Nordin JD, Lee GM.
    Pharmacoepidemiol Drug Saf; 2014 May 15; 23(5):548-53. PubMed ID: 24497128
    [Abstract] [Full Text] [Related]

  • 31. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR, Nichol KL, Belshe RB, Frick KD, Li SX, Boscoe A, Rousculp MD, Mahadevia PJ.
    Vaccine; 2008 Jun 02; 26(23):2841-8. PubMed ID: 18462851
    [Abstract] [Full Text] [Related]

  • 32. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep 02; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 33. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.
    King JC, Fast PE, Zangwill KM, Weinberg GA, Wolff M, Yan L, Newman F, Belshe RB, Kovacs A, Deville JG, Jelonek M, HIV Influenza Study Group.
    Pediatr Infect Dis J; 2001 Dec 02; 20(12):1124-31. PubMed ID: 11740317
    [Abstract] [Full Text] [Related]

  • 34. The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies.
    Ambrose CS, Wu X, Knuf M, Wutzler P.
    Vaccine; 2012 Jan 20; 30(5):886-92. PubMed ID: 22155144
    [Abstract] [Full Text] [Related]

  • 35. Live attenuated influenza vaccine use and safety in children and adults with asthma.
    Duffy J, Lewis M, Harrington T, Baxter R, Belongia EA, Jackson LA, Jacobsen SJ, Lee GM, Naleway AL, Nordin J, Daley MF, Vaccine Safety Datalink.
    Ann Allergy Asthma Immunol; 2017 Apr 20; 118(4):439-444. PubMed ID: 28390584
    [Abstract] [Full Text] [Related]

  • 36. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Dec 11; 58(48):1351-6. PubMed ID: 20010511
    [Abstract] [Full Text] [Related]

  • 37. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States.
    Caspard H, Gaglani M, Clipper L, Belongia EA, McLean HQ, Griffin MR, Talbot HK, Poehling KA, Peters TR, Veney N, Ambrose CS.
    Vaccine; 2016 Jan 02; 34(1):77-82. PubMed ID: 26589519
    [Abstract] [Full Text] [Related]

  • 38. Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses.
    Abente EJ, Rajao DS, Santos J, Kaplan BS, Nicholson TL, Brockmeier SL, Gauger PC, Perez DR, Vincent AL.
    J Virol; 2018 Nov 15; 92(22):. PubMed ID: 30185589
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years.
    Block SL, Toback SL, Yi T, Ambrose CS.
    Clin Ther; 2009 Oct 15; 31(10):2140-7. PubMed ID: 19922885
    [Abstract] [Full Text] [Related]

  • 40. Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh.
    Ortiz JR, Goswami D, Lewis KD, Sharmeen AT, Ahmed M, Rahman M, Rahman MZ, Feser J, Neuzil KM, Brooks WA.
    Vaccine; 2015 Jun 26; 33(29):3415-21. PubMed ID: 25917680
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 91.